Skip to main content

Clinical Cellular Therapy Research Laboratory (LTCC)

Description

The Institut Bordet Clinical Cellular Therapy Research Laboratory (LTCC) is dedicated to fundamental and translational research in the fields of haematology and immunology cellular therapy.

The LTCC’s main objectives concern:

  • study of the interaction between leukaemic cells and their microenvironment;
  • establishment of new prognostic factors;
  • development of new therapeutic strategies.

Within the field of cellular therapy, the LTCC is studying the functional characterisation of mesenchymal stromal cells obtained from different tissues and their manipulation with a view to increasing their therapeutic potential.

Research projects

Project 1

Discovering new altered signalling pathways leading to Richter syndrome in patients affected by chronic lymphoid leukaemia via whole genome sequencing.

Project 2

Phenotypical Characterization and functional Impact of extracellular vesicles from mesenchymal stromal cells on Chronic Lymphocytic Leukemia B-cells.

Project 3

Proteome, miRNome and immunobiological properties of mesenchymal stromal cells of different origins and of extracellular vesicles derived from these: influence of an inflammatory and infectious environment.
  • Collaborations :
    • Department of In Vitro Toxicology and Dermato-Cosmetology, Center for Pharmaceutical Research, VUB (De Kock J-Rogiers V)
    • Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Hadath, Lebanon
    • Laboratory of Pediatric Hepatology and Cell Therapy, Institute of Experimental & Clinical Research, Université Catholique de Louvain, Brussels, Belgium (Pr E. Sokal, Dr M. Najimi)
  • Funding : FNRS-Télévie, Fonds Lambeau-Marteaux

Project 4

Chronic lymphoid leukaemia:
- Prognostic factors (cellular and molecular) of CLL
Role of microenvironment microvesicles
-
Predictive molecular markers for Richter transformation

Project 5

Medullary microenvironment
Immunomodulation by mesenchymal stem cells
  • Project leader : Medhi Najar (PhD)
  • Funding : Télévie, FNRS

Project 6

Medullary microenvironment
Differential potential of mesenchymal stem cells

Our team

Laboratory head
Laurence Lagneaux, PhD

The team
Basile Stamatopoulos, PhD
Medhi Najar, PhD
Emerence Crompot, PhD
Karlien Pieters, technologue de laboratoire

 Scientific publications

Aldehyde dehydrogenase activity of Wharton jelly mesenchymal stromal cells: isolation and characterization.

Authors : Najar M, Crompot E, van Grunsven LA, Dollé L, Lagneaux L
Year : 2019
Journal : Cytotechnology
Volume : 71
Pages : 427-441

Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells.

Authors : Najar M, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Year : 2019
Journal : Cytotechnology
Volume : 71
Pages : 375-388

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.

Authors : Chi VLD, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, Gu-Trantien C, Krayem M, Duvillier H, Lodewyckx JN, Willard-Gallo K, Sibille C, Bron D
Year : 2019
Journal : BMC Cancer
Volume : 19
Pages : 81

Human CD8<sup>+</sup> CD25 <sup>+</sup> CD127 <sup>low</sup> regulatory T cells: microRNA signature and impact on TGF-ß and IL-10 expression.

Authors : Rouas R, Merimi M, Najar M, Zein NE, Fayyad-Kazan M, Berehab M, Agha D, Bron D, Burny A, Rachidi W, Badran B, Lewalle P, Fayyad-Kazan H
Year : 2019
Journal : J Cell Physiol

Mesenchymal stromal cells and natural killer cells: a complex story of love and hate.

Authors : Najar M, Fayyad-Kazan M, Merimi M, Burny A, Bron D, Fayyad-Kazan H, Meuleman N, Lagneaux L
Year : 2019
Journal : Curr Stem Cell Res Ther
Volume : 14(1)
Pages : 14-21

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more